About Interstitial collagenase
Interstitial collagenase (MMP1) is a protein
from Homo sapiens identified by UniProt accession
P03956, 469 residues long.
MolForge cross-references it against 0 known binders and
935 disease associations.
Target properties
| Protein name | Interstitial collagenase |
| UniProt accession | P03956 |
| Gene | MMP1 |
| Organism | Homo sapiens |
| Length | 469 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (10)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (935)
Diseases linked to this target (Open Targets).
- acne · score 0.61
- Helicobacter pylori infectious disease · score 0.61
- rosacea · score 0.60
- COVID-19 · score 0.60
- periodontitis · score 0.59
- infection · score 0.59
- Lyme disease · score 0.57
- chronic obstructive pulmonary disease · score 0.57
- Borrelia infectious disease · score 0.56
- ulcerative colitis · score 0.56
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P03956-F1 | alphafold | PREDICTED | 91.22 | — |
Amino-acid sequence (469 residues)
MHSFPPLLLL LFWGVVSHSF PATLETQEQD VDLVQKYLEK YYNLKNDGRQ VEKRRNSGPV VEKLKQMQEF FGLKVTGKPD AETLKVMKQP RCGVPDVAQF VLTEGNPRWE QTHLTYRIEN YTPDLPRADV DHAIEKAFQL WSNVTPLTFT KVSEGQADIM ISFVRGDHRD NSPFDGPGGN LAHAFQPGPG IGGDAHFDED ERWTNNFREY NLHRVAAHEL GHSLGLSHST DIGALMYPSY TFSGDVQLAQ DDIDGIQAIY GRSQNPVQPI GPQTPKACDS KLTFDAITTI RGEVMFFKDR FYMRTNPFYP EVELNFISVF WPQLPNGLEA AYEFADRDEV RFFKGNKYWA VQGQNVLHGY PKDIYSSFGF PRTVKHIDAA LSEENTGKTY FFVANKYWRY DEYKRSMDPG YPKMIAHDFP GIGHKVDAVF MKDGFFYFFH GTRQYKFDPK TKRILTLQKA NSWFNCRKN
Explore Interstitial collagenase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets